Christopher M. Bussineau
Chief Operating Officer at BioVascular, Inc.
Profile
Christopher M.
Bussineau is currently the Vice President-Pharmaceutical Operations at BioVascular, Inc. He previously worked as the Senior Director-Technical Operations at Chiron Corp.
and as the Vice President & General Manager at Cambrex Bio Science Baltimore, Inc. Bussineau holds a doctorate degree from Rice University and an undergraduate degree from the University of California San Diego.
Christopher M. Bussineau active positions
| Companies | Position | Start |
|---|---|---|
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Chief Operating Officer | - |
Former positions of Christopher M. Bussineau
| Companies | Position | End |
|---|---|---|
| Cambrex Bio Science Baltimore, Inc. | Corporate Officer/Principal | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Chief Tech/Sci/R&D Officer | - |
Training of Christopher M. Bussineau
| Rice University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| Cambrex Bio Science Baltimore, Inc. |
- Stock Market
- Insiders
- Christopher M. Bussineau
